Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

NCT00997152 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: JTT-654
DRUG: JTT-654 Placebo

Sponsor

Akros Pharma Inc.